Hidetoshi Eguchi

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Yoshito Tomimaru · 7 shared papers, 2025–2026 · strength 2.05
   • Paper Adjuvant treatment after surgical resection of pancreatic cancer. DOI 10.1007/s00595-025-03109-8↗
   • Paper Prognostic significance of neoadjuvant gemcitabine and S-1 chemotherapy with or without concurrent radiation in patient… DOI 10.1016/j.surg.2025.109864↗
   • Paper Prognostic impact of post-neoadjuvant CA19-9 values in pancreatic cancer: more pronounced following neoadjuvant chemoth… DOI 10.1016/j.pan.2025.06.016↗
2. Yuichiro Doki · 8 shared papers, 2017–2026 · strength 1.68
   • Paper Prognostic significance of neoadjuvant gemcitabine and S-1 chemotherapy with or without concurrent radiation in patient… DOI 10.1016/j.surg.2025.109864↗
   • Paper Prognostic impact of post-neoadjuvant CA19-9 values in pancreatic cancer: more pronounced following neoadjuvant chemoth… DOI 10.1016/j.pan.2025.06.016↗
   • Paper miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Tra… DOI 10.1245/s10434-024-16115-w↗
3. Daisaku Yamada · 8 shared papers, 2017–2026 · strength 1.68
   • Paper Prognostic significance of neoadjuvant gemcitabine and S-1 chemotherapy with or without concurrent radiation in patient… DOI 10.1016/j.surg.2025.109864↗
   • Paper Prognostic impact of post-neoadjuvant CA19-9 values in pancreatic cancer: more pronounced following neoadjuvant chemoth… DOI 10.1016/j.pan.2025.06.016↗
   • Paper miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Tra… DOI 10.1245/s10434-024-16115-w↗
4. Tadafumi Asaoka · 6 shared papers, 2017–2025 · strength 1.14
   • Paper miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Tra… DOI 10.1245/s10434-024-16115-w↗
   • Paper ASO Author Reflections: Potential of Peripheral Plasma Exosomal miRNA: miR-6855-5p Could Predict Radiosensitivity in Pa… DOI 10.1245/s10434-024-16235-3↗
   • Paper Surgical outcomes of histopathological stage I pancreatic cancer with special reference to oncological differences betw… DOI 10.1016/j.suronc.2025.102225↗
5. Yoshifumi Iwagami · 6 shared papers, 2017–2025 · strength 1.14
   • Paper miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Tra… DOI 10.1245/s10434-024-16115-w↗
   • Paper ASO Author Reflections: Potential of Peripheral Plasma Exosomal miRNA: miR-6855-5p Could Predict Radiosensitivity in Pa… DOI 10.1245/s10434-024-16235-3↗
   • Paper Surgical outcomes of histopathological stage I pancreatic cancer with special reference to oncological differences betw… DOI 10.1016/j.suronc.2025.102225↗
6. Kazuki Sasaki · 5 shared papers, 2025 · strength 1.13
   • Paper Prognostic impact of post-neoadjuvant CA19-9 values in pancreatic cancer: more pronounced following neoadjuvant chemoth… DOI 10.1016/j.pan.2025.06.016↗
   • Paper miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Tra… DOI 10.1245/s10434-024-16115-w↗
   • Paper ASO Author Reflections: Potential of Peripheral Plasma Exosomal miRNA: miR-6855-5p Could Predict Radiosensitivity in Pa… DOI 10.1245/s10434-024-16235-3↗
7. Hirofumi Akita · 4 shared papers, 2025–2026 · strength 0.96
   • Paper Prognostic significance of neoadjuvant gemcitabine and S-1 chemotherapy with or without concurrent radiation in patient… DOI 10.1016/j.surg.2025.109864↗
   • Paper Prognostic impact of post-neoadjuvant CA19-9 values in pancreatic cancer: more pronounced following neoadjuvant chemoth… DOI 10.1016/j.pan.2025.06.016↗
   • Paper Surgical outcomes of histopathological stage I pancreatic cancer with special reference to oncological differences betw… DOI 10.1016/j.suronc.2025.102225↗
8. Yutaka Takeda · 3 shared papers, 2017–2026 · strength 0.55
   • Paper Prognostic significance of neoadjuvant gemcitabine and S-1 chemotherapy with or without concurrent radiation in patient… DOI 10.1016/j.surg.2025.109864↗
   • Paper Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/… DOI 10.1038/s41598-025-23185-7↗
   • Paper Two cases of resectable pancreatic cancer diagnosed by open surgical biopsy after endoscopic ultrasound fine-needle asp… DOI 10.1186/s40792-017-0314-2↗
9. Shinichiro Hasegawa · 2 shared papers, 2025–2026 · strength 0.51
   • Paper Prognostic significance of neoadjuvant gemcitabine and S-1 chemotherapy with or without concurrent radiation in patient… DOI 10.1016/j.surg.2025.109864↗
   • Paper Surgical outcomes of histopathological stage I pancreatic cancer with special reference to oncological differences betw… DOI 10.1016/j.suronc.2025.102225↗
10. Masahiko Kubo · 2 shared papers, 2025 · strength 0.45
    • Paper miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Tra… DOI 10.1245/s10434-024-16115-w↗
    • Paper ASO Author Reflections: Potential of Peripheral Plasma Exosomal miRNA: miR-6855-5p Could Predict Radiosensitivity in Pa… DOI 10.1245/s10434-024-16235-3↗
11. Hiroki Ueda · 2 shared papers, 2025 · strength 0.45
    • Paper miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Tra… DOI 10.1245/s10434-024-16115-w↗
    • Paper ASO Author Reflections: Potential of Peripheral Plasma Exosomal miRNA: miR-6855-5p Could Predict Radiosensitivity in Pa… DOI 10.1245/s10434-024-16235-3↗
12. Masahiro Tanemura · 2 shared papers, 2017–2025 · strength 0.26
    • Paper Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/… DOI 10.1038/s41598-025-23185-7↗
    • Paper Two cases of resectable pancreatic cancer diagnosed by open surgical biopsy after endoscopic ultrasound fine-needle asp… DOI 10.1186/s40792-017-0314-2↗
13. Satoru Miyahara · 1 shared paper, 2025 · strength 0.25
    • Paper Prognostic impact of post-neoadjuvant CA19-9 values in pancreatic cancer: more pronounced following neoadjuvant chemoth… DOI 10.1016/j.pan.2025.06.016↗
14. Naoko Sekiguchi · 1 shared paper, 2025 · strength 0.22
    • Paper Surgical outcomes of histopathological stage I pancreatic cancer with special reference to oncological differences betw… DOI 10.1016/j.suronc.2025.102225↗
15. Ryosuke Maki · 1 shared paper, 2025 · strength 0.22
    • Paper Efficacy of SOAT1 Inhibitors Against Pancreatic Cancer with TP53 Mutations. DOI 10.1245/s10434-025-17482-8↗
16. Hidenori Takahashi · 1 shared paper, 2025 · strength 0.22
    • Paper Efficacy of SOAT1 Inhibitors Against Pancreatic Cancer with TP53 Mutations. DOI 10.1245/s10434-025-17482-8↗
17. Osakuni Morimoto · 1 shared paper, 2025 · strength 0.20
    • Paper Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/… DOI 10.1038/s41598-025-23185-7↗
18. Masanori Tsujie · 1 shared paper, 2025 · strength 0.20
    • Paper Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/… DOI 10.1038/s41598-025-23185-7↗
19. Reishi Toshiyama · 1 shared paper, 2017 · strength 0.06
    • Paper Two cases of resectable pancreatic cancer diagnosed by open surgical biopsy after endoscopic ultrasound fine-needle asp… DOI 10.1186/s40792-017-0314-2↗
20. Kunihito Gotoh · 1 shared paper, 2017 · strength 0.06
    • Paper Two cases of resectable pancreatic cancer diagnosed by open surgical biopsy after endoscopic ultrasound fine-needle asp… DOI 10.1186/s40792-017-0314-2↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.